Fongit

BrainScape Medical is a Swiss life sciences startup focused on developing an end-to-end solution for brain disorder management and care, addressing many limitations of current approaches.

Miloo is a Swiss-quality electric mobility company that designs and manufactures high-performance electric bikes for urban transport. Its e-bikes are engineered to go the extra mile with style, power, and a bold attitude, and are assembled in Switzerland to meet high safety and performance standards. Miloo aims to redefine urban mobility by offering a connected, capable, and enjoyable riding experience that provides more range, comfort, and freedom for daily commutes. The company emphasizes sustainable travel through electric two-wheel vehicles, combining visionary engineering with digital tools and attentive service to deliver an extra mile on every ride and help riders move through cities effortlessly.

Cerret, a Swiss-based jewelry brand, specializes in designing and manufacturing smart bracelets for women's safety. Their products, equipped with advanced technology, allow users to discreetly alert loved ones or authorities in case of an emergency, providing a sense of security and peace of mind.

HekeTiss SA is a spin-off from the University Hospitals of Geneva and the University of Geneva, specializing in the manufacturing of medical and dental instruments. The company has developed TrophiPatch, an innovative cellular patch designed to enhance wound healing. This product closely resembles natural skin and is engineered from stem cells derived from human adipose tissue. TrophiPatch actively secretes various factors that facilitate the wound healing process, effectively restoring blood vessels in the affected area. By promoting efficient healing, HekeTiss aims to enable healthcare providers to offer effective and cost-efficient treatments for chronic ulcers while significantly reducing the time required for recovery.

Antion Biosciences is a Geneva-based biotechnology company focused on cell and gene engineering to develop off-the-shelf therapies for diseases with significant unmet medical needs. Its proprietary technology enables multiplexed, modular modification of therapeutic cells, supporting allogeneic approaches and the potential to enhance safety and efficacy of next-generation therapies. The company is repurposing its miCAR19 programs for autoimmune diseases and advancing its lead product miCAR7, backed by in vivo proof-of-concept data. By leveraging multiplex engineering, Antion aims to deliver best-in-class treatments for B-cell-driven autoimmune conditions, with notable preclinical progress and human proof-of-concept milestones to date.

HeroSupport is a medical device manufacturing company founded in 2019 and based in Veyrier, Geneva. The company specializes in creating medical immobilization devices designed to enhance patient comfort during clinical procedures. Its innovative technology transforms imaging and treatment tables into personalized support solutions, specifically catering to the needs of patients undergoing prone breast radiotherapy. This approach allows patients to benefit from tailored support, eliminating the need for them to adjust to the standard table. By improving patient comfort, HeroSupport enables healthcare providers to deliver more effective and cost-efficient cancer treatment.

Transmutex is a Swiss company founded in 2019 that specializes in innovative nuclear technology aimed at significantly reducing existing nuclear waste. The company leverages advanced techniques, including particle accelerators, to transmute long-lived nuclear waste into less harmful materials while simultaneously generating carbon-free energy. This energy can be reintegrated into the power grid or utilized for green hydrogen production. Comprising a diverse team of physicists, computer scientists, and environmentalists, Transmutex is pioneering a new approach to nuclear energy that offers scalable, carbon-free solutions without the typical challenges associated with conventional nuclear power plants.

Founded in Geneva in 2017, KYLYS is a Swiss company specializing in biomolecule-based products. It offers innovative, safe, and effective solutions for medical, surgical, and cosmetic needs, with a focus on hyaluronic acid pearls.

Plair SA is a Swiss company specializing in the development and manufacturing of advanced systems for preventive environmental monitoring, particularly focusing on air quality. Founded in 2014 and based in Plan-les-Ouates, Switzerland, Plair SA designs instruments that enable continuous real-time measurements of fine airborne particles. Its notable products include the Rapid-E, which analyzes single aerosol particles, and the Particle Analyzer PA-300, capable of detecting, identifying, and classifying various airborne entities such as pollen, fungal spores, soot, and pollutants. The company offers solutions for airborne allergen monitoring, air quality assessment, and bioaerosol tracking, providing crucial data on atmospheric aerosol concentrations. Plair SA originated as a spin-off from the University of Geneva, reflecting its strong foundation in research and innovation.

Endotelix is a Swiss biotechnology company and a spin-off from the University of Geneva focused on antiphospholipid syndrome. It develops diagnostic tests and treatment options, aiming to deliver fast, sensitive solutions for the condition. The company provides diagnostic tools, therapies, and supports clinical research to assist clinicians in diagnosing antiphospholipid syndrome and identifying effective treatments.

EBAMed develops a non-invasive ultrasound-based device to monitor and treat heart motion using proton beams. Founded in 2018, the company is based in Geneva, Switzerland.

Terapet specializes in advanced proton therapy for cancer treatment. Founded by physicists Christina Vallgren, Marcus Palm, and Professor Raymond Miralbell from Geneva University Hospitals, the company offers precise radiotherapy that minimizes harm to healthy cells. Incorporated in 2019, Terapet is based in Geneva, Switzerland.

Transmutex is a Swiss company founded in 2019 that specializes in innovative nuclear technology aimed at significantly reducing existing nuclear waste. The company leverages advanced techniques, including particle accelerators, to transmute long-lived nuclear waste into less harmful materials while simultaneously generating carbon-free energy. This energy can be reintegrated into the power grid or utilized for green hydrogen production. Comprising a diverse team of physicists, computer scientists, and environmentalists, Transmutex is pioneering a new approach to nuclear energy that offers scalable, carbon-free solutions without the typical challenges associated with conventional nuclear power plants.

GliaPharm is a Swiss biotechnology company focused on developing treatments for neurological and psychiatric disorders by targeting glial cells to support brain metabolism. It has developed the GliaX platform to identify drugs that modulate glial activity and energy metabolism. The platform combines high-throughput screening using enzymatic and primary-cell assays with metabolic characterization of compounds in vitro in primary brain cell cultures and in vivo in rodent brains. Research includes various rodent models of brain aging, Alzheimer's disease, and ALS, with selective contract research organizations handling parts of the drug-development process. Founded in 2016 and based in Geneva, GliaPharm pursues glia-mediated neuroprotection and maintenance of cognitive function.

HekeTiss SA is a spin-off from the University Hospitals of Geneva and the University of Geneva, specializing in the manufacturing of medical and dental instruments. The company has developed TrophiPatch, an innovative cellular patch designed to enhance wound healing. This product closely resembles natural skin and is engineered from stem cells derived from human adipose tissue. TrophiPatch actively secretes various factors that facilitate the wound healing process, effectively restoring blood vessels in the affected area. By promoting efficient healing, HekeTiss aims to enable healthcare providers to offer effective and cost-efficient treatments for chronic ulcers while significantly reducing the time required for recovery.

ABCDx is a Geneva-based company that develops and validates biomarker panels and related diagnostics for brain injury care. It aims to identify patients at risk of severe long-term complications after traumatic brain injury or stroke and to educate clinicians on using these tests. The company is building a platform that analyzes brain biomarkers from a finger-prick blood sample to enable rapid, point-of-care diagnosis of brain injuries, supporting timely treatment decisions. Founded in 2014 by researchers from the University of Geneva and related institutes, ABCDx translates biomarker discovery and clinical validation into practical tools for stroke and brain injury management.

HeroSupport is a medical device manufacturing company founded in 2019 and based in Veyrier, Geneva. The company specializes in creating medical immobilization devices designed to enhance patient comfort during clinical procedures. Its innovative technology transforms imaging and treatment tables into personalized support solutions, specifically catering to the needs of patients undergoing prone breast radiotherapy. This approach allows patients to benefit from tailored support, eliminating the need for them to adjust to the standard table. By improving patient comfort, HeroSupport enables healthcare providers to deliver more effective and cost-efficient cancer treatment.

Founded in 2018, CommoChain specializes in developing a platform for commodity trading. It enhances transaction security through blockchain and smart contract technology, streamlining back-office operations for exporters and importers of commodities and raw materials.

Quantum Integrity SA is a Swiss company based in Geneva, founded in 2017, that specializes in software development for forensic analysis of digital images. The company's technology examines images on a pixel-by-pixel basis to identify manipulations and potential forgeries, regardless of the methods or software employed in their alteration. By focusing on accuracy in forgery detection, Quantum Integrity enhances the security of cyber communications and ensures the integrity of digital media.

Founded in 2015, Kejako is a Swiss medical device company specializing in ophthalmic surgery. It develops non-invasive solutions to address presbyopia, a gradual loss of visual accommodation, using advanced numerical simulations for personalized treatment.

Alohi provides a cloud-based communication platform for entrepreneurs, small businesses, and individual consumers, enabling local phone numbers in multiple countries, customizable greetings and extensions, call forwarding, voicemail, fax, and announcements. The platform supports cross-channel connectivity across phone and internet, improving collaboration and reach. The company develops two platforms for self-service communications and legally binding electronic signatures, including Sign.Plus, Fax.Plus, and Scan.Plus, to streamline workflows. It emphasizes secure, encrypted electronic signatures, online faxing, and AI-powered mobile scanning, integrated with existing applications to boost productivity, data security, and regulatory compliance. Founded in 2015 and based in Switzerland, Alohi aims to simplify communications and document processes for businesses and individual users.

Gmelius develops a software extension that transforms email inboxes into collaborative workspaces. It automates workflows, enables real-time team collaboration, and integrates with other tools like Slack or Trello. Founded in 2016, Gmelius is headquartered in Switzerland and serves over 10,000 paid customers, including notable companies such as Netflix.

Founded in 2016, Quantreex offers a web-based trading platform that enables users to create automated trading strategies using artificial intelligence and machine learning. The platform designs strategies, verifies them through back tests on multiple instruments and markets, and allows clients to deploy these strategies live.

ProtonVPN is Swiss-based VPN service, created by the same team of CERN scientists who created ProtonMail. ProtonVPN makes it possible to access the Internet without censorship and surveillance.

TwentyGreen is a Swiss company that specializes in the production of probiotic feed supplements aimed at enhancing sustainable animal farming practices. Founded in 2015 and based in Root, Switzerland, the company has developed a unique triple active probiotic product that addresses challenges faced in intensive animal farming, such as improving digestion, enhancing feed conversion ratios, and reducing disease and pollution. The probiotic supplement is grounded in research from the École Polytechnique Fédérale de Lausanne, focusing on the enhancement of gut microbiota, which is crucial for food metabolism and immune defense. Targeting animal farmers, feed suppliers, and large retailers, TwentyGreen aims to capture a 10% share of the rapidly growing global animal feed probiotic market, which exceeds $4 billion annually. The commercialization of their product involves rigorous research and development in collaboration with esteemed academic partners to meet regulatory standards for animal feed.

Prodibi is a professional image platform based in Geneva, Switzerland, that addresses various challenges associated with online image display, enhancing brand ROI and user engagement. Established in 2011, the platform offers a subscription-based service that simplifies the process of sharing high-quality images on web and mobile. By automatically uploading, encoding, and delivering images, Prodibi allows photographers, artists, and web publishers to showcase their work without sacrificing speed or quality. The solution effectively resolves issues such as color management, pixel density, and responsiveness, which can be time-consuming and costly for graphic designers. Prodibi’s capabilities enable users to replace images seamlessly without the need for website redesigns or new photo shoots, delivering an exceptional visual experience that aligns with the prestige of their brands.

Expedismart operates a comparison platform for courier services, enabling users to select the most suitable option based on quality, accuracy, preferred time, and price. The platform facilitates online booking for transporting parcels within Switzerland or internationally.

Silver Wave is a Swiss company based in Geneva, founded by expert professionals from the pharma & medical device industries. Building on 25 years of experience, the team at Silver Wave has a leading reputation in the field of aesthetics, with experience in research and development as well as manufacturing and management that extends to many global healthcare companies. Silver Wave is built on the team’s experience and passion.

Multiwave Technologies develops breakthrough magnetic resonance imaging and positron emission tomography devices, including metamaterial MRI antennas designed by its French unit. The company aims to improve MRI image quality and support clinical decision making, including portable MRI capabilities and sensor-based performance analysis. Founded in 2015 in Switzerland, it is headquartered in Geneva and conducts research and development in France, reflecting an international footprint. The business is recognized for its metamaterial MRI antenna design and positions itself as a deep science imaging innovator in neurology and other medical imaging applications.

Planet Intus SA is a Swiss company specializing in the design and development of indoor geolocation software. Founded in 2014 and headquartered in Carouge, Switzerland, the company leverages a combination of French telecommunications expertise and Swiss quality standards. Planet Intus provides both active and passive geolocation infrastructure, enabling a variety of indoor guidance services and applications for end users. Its offerings include preparation and navigation assistance, opportunity tracking, safety services, and marketing data analysis for professionals, enhancing customer experience in sectors such as retail, leisure, travel, and healthcare. The company's innovative 3D-integrated platform utilizes indoor positioning technologies and user behavior analysis, allowing clients to navigate locations like exhibitions efficiently. A team of skilled engineers and technicians supports Planet Intus, focusing on Geographic Information Systems, mobile app development, and big data analytics to deliver superior operational insights and profitability for businesses.

InvestGlass is a Swiss-based company founded in 2013, specializing in the development of a web-based platform that provides a comprehensive suite of tools for client and customer management, particularly in the financial sector. The platform integrates features such as digital onboarding, customer relationship management, portfolio management, and marketing automation, all designed to enhance operational efficiency for financial institutions and advisors. InvestGlass also offers a Strategy Tutor to assist investors in maintaining their investment strategies, alongside access to global market data, news, and forecasts. Additionally, an Educational Portal provides resources such as articles, tools, and videos aimed at improving market understanding. By leveraging artificial intelligence and a secure Swiss cloud infrastructure, InvestGlass helps clients navigate compliance challenges while focusing on delivering high-quality investment advice.

Telexoo is a Geneva-based company that offers an online financial platform for currency exchange at competitive rates. Unlike traditional services, Telexoo provides a more personal approach, allowing users to connect directly with exchange specialists via phone or email, eliminating the need for call centers or ticket systems. Users can create a free account on the platform to transfer funds from their bank for exchange. The transactions are executed in real-time based on the interbank rate, enabling users to send exchanged currency seamlessly to any destination. Telexoo focuses on providing accessible and efficient currency exchange services.

Aptissen SA, founded in 2013 as a spin-off of ANTEIS, is a Swiss company based in Plan-les-Ouates, specializing in the development and commercialization of hyaluronic acid polymer-based injectable medicinal products. The company focuses on aesthetic medicine, ophthalmology, and orthopedics, with notable innovations such as the Synolis VA range, which combines hyaluronic acid and sorbitol to provide rapid mobility recovery and effective pain relief for osteoarthritis patients. Aptissen also offers a food supplement called Cartylis aimed at joint health. Its products are distributed through a global network of distributors in over 50 countries, including Europe, South America, Canada, the Middle East, and Asia. The company operates subsidiaries in Italy, Poland, and France, and maintains certifications including CE, ISO13485, MDSAP, and GMP compliance, ensuring adherence to high-quality standards. Aptissen relies on subcontracting for production, sourcing materials from three suppliers located in Europe.